Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,229,017
  • Shares Outstanding, K 236,390
  • Annual Sales, $ 258,220 K
  • Annual Income, $ -28,240 K
  • EBIT $ 115 M
  • EBITDA $ 126 M
  • 60-Month Beta 0.70
  • Price/Sales 15.94
  • Price/Cash Flow 342.60
  • Price/Book 17.75

Options Overview Details

View History
  • Implied Volatility 62.36% ( +4.29%)
  • Historical Volatility 51.38%
  • IV Percentile 48%
  • IV Rank 27.62%
  • IV High 171.68% on 04/05/24
  • IV Low 20.64% on 02/13/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 493
  • Volume Avg (30-Day) 2,623
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 51,578
  • Open Int (30-Day) 59,579

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.17
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.15
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +325.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.06 +1.82%
on 12/27/24
21.78 -20.25%
on 11/29/24
-4.46 (-20.43%)
since 11/27/24
3-Month
15.33 +13.31%
on 10/21/24
23.64 -26.52%
on 11/11/24
-2.01 (-10.39%)
since 09/27/24
52-Week
4.37 +297.48%
on 01/03/24
23.64 -26.52%
on 11/11/24
+12.88 (+286.86%)
since 12/27/23

Most Recent Stories

More News
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

For Immediate ReleaseChicago, IL – December 26, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

CDXC : 5.47 (-2.50%)
ADMA : 17.36 (-2.96%)
TARS : 55.04 (+1.27%)
STOK : 11.03 (-1.87%)
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains slowed down in the second half of 2024. The downside in the second half was due...

CDXC : 5.47 (-2.50%)
ADMA : 17.36 (-2.96%)
TARS : 55.04 (+1.27%)
STOK : 11.03 (-1.87%)
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA : 17.36 (-2.96%)
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares

Brad L. Tade, the CFO and Treasurer of $ADMA ($ADMA), sold 15,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.0% of their...

ADMA : 17.36 (-2.96%)
Adma Biologics: Q3 Earnings Snapshot

Adma Biologics: Q3 Earnings Snapshot

ADMA : 17.36 (-2.96%)
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

ADMA : 17.36 (-2.96%)
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

ADMA : 17.36 (-2.96%)
Adma Biologics: Q2 Earnings Snapshot

Adma Biologics: Q2 Earnings Snapshot

ADMA : 17.36 (-2.96%)
Adma Biologics: Q1 Earnings Snapshot

Adma Biologics: Q1 Earnings Snapshot

ADMA : 17.36 (-2.96%)
Chart of the Day: ADMA Biologics - Hitting New Highs

The Chart of the Day belongs to the biomedical company ADMA Biologics (ADMA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

ADMA : 17.36 (-2.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying...

See More

Key Turning Points

3rd Resistance Point 18.83
2nd Resistance Point 18.36
1st Resistance Point 18.13
Last Price 17.36
1st Support Level 17.43
2nd Support Level 16.96
3rd Support Level 16.73

See More

52-Week High 23.64
Last Price 17.36
Fibonacci 61.8% 16.28
Fibonacci 50% 14.00
Fibonacci 38.2% 11.73
52-Week Low 4.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar